Editorial: Personalized cancer treatment

Curr Mol Pharmacol. 2014;7(1):2-3. doi: 10.2174/187446720701150105170527.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Biomarkers / metabolism
  • ErbB Receptors / metabolism
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Precision Medicine*

Substances

  • Antineoplastic Agents
  • Biomarkers
  • ErbB Receptors